Skip to content
  • Sunday, 26 July 2026
  • 1:43 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
Laboratory Automation & Robotics

As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer

Lana Keisha Jul 24, 2026 0

The biopharmaceutical industry is grappling with a profound challenge: the silent erosion of critical process knowledge, particularly "tacit knowledge," during…

Read More
Laboratory Automation & Robotics

As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer

Lana Keisha Jul 17, 2026 0

The pharmaceutical industry, particularly the rapidly evolving biopharmaceutical sector, faces a silent but significant challenge: the erosion of critical "tacit…

Read More
Laboratory Automation & Robotics

As Cell Therapies Scale and CDMOs Cut Staff, Process Know-How Is Often Getting Lost in Tech Transfer

Lana Keisha Jul 10, 2026 0

The biopharmaceutical industry is grappling with a critical challenge: the silent erosion of invaluable "tacit knowledge" during technology transfer processes.…

Read More
Laboratory Automation & Robotics

As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer

Lana Keisha Jun 23, 2026 0

The biopharmaceutical industry, in its relentless pursuit of innovation and efficiency, faces a silent but profound challenge: the erosion of…

Read More
Data Science & Bioinformatics

Getting Started with smolagents: Build Your First Code Agent in 15 Minutes

Evan Lee Salim Mar 26, 2026 0

The landscape of artificial intelligence is undergoing a profound transformation, moving beyond mere conversational interactions with large language models (LLMs)…

Read More
Data Science & Bioinformatics

Getting Started with Nanobot: Build Your First AI Agent – KDnuggets

Evan Lee Salim Mar 24, 2026 0

The increasing demand for personalized digital assistance has fueled the development of AI agents designed to automate tasks, provide instant…

Read More
Revolutionizing Industrial Separation: Indian and International Researchers Develop High-Precision POMbrane Technology for Sustainable ManufacturingPharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report RevealsBioTechniques Image Competition 2026 Extends Deadline and Boosts Prize for Scientific ArtistryUniversal Physical Constants and the Precise Viscosity Requirements for Biological Life
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ